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With this case report of successful biofeedback
treatment for a severely disordered and treatment-
refractory forensic patient, the authors contribute
to arguments for consideration of the inclusion of
biofeedback for a group of extremely challenging
patients. The term ‘complex patient’ barely captures
the patient MN, whose psychopathology cuts across
diagnostic borders and includes a mixed personality
disorder with borderline, antisocial and histrionic
features, paedophilia, attentional difﬁculties that
may meet criteria for Attention Deﬁcit Disorder/
Attention Deﬁcit Hyperactivity Disorder, border-
line intellectual functioning and an unspeciﬁed
mood disorder. Prior to his transfer from a prison to
a forensic hospital, the unremitting severity of his
sexual deviance led to placement on a testosterone-
lowering agent, and his level of mood instability
resulted in treatment with carbamazepine.
Strengths of this case report include the extensive
initial psychometric and psychological evaluation
of the patient and the documentation of signiﬁcant
post-treatment improvement in biobehavioral
(Flanker test) and electrophysiological (Go/No Go
contingent negative variation) measures, as well as
patient self-report of decreased impulsivity and
improvement in attention/cognition at the study
endpoint and at 3months of follow-up.
This paper is a welcome addition to the literature
on therapeutic interventions in severely personality
disordered patients from several perspectives. Much
of this patient’s history and behavioural presenta-
tion are characteristics of antisocial personality
disorder (ASPD) and accompanying paedophilia,
areas of psychopathology much neglected in psy-
chiatric literature, with diagnoses for which thera-
peutic pessimism bordering on nihilism has led in
the US to relegation of these patients to the crimi-
nal justice system. Patients with ASPD have signif-
icant deﬁcits in mentalization, attachment and
impulse control (Leichsenring et al., 2003), ego
weaknesses that make them poor candidates for
many psychotherapies and that render these
patients destructive to a hospital-based therapeutic
milieu. Indeed, MN had shown poor motivation
and compliance with routine psychotherapies in
the past. An advantage for forensic-type patients
of neurofeedback treatments is that they work at
basic neurophysiologic levels and focus on brain
functioning rather than psychopathology; conse-
quently these procedures largely bypass the need
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for the classic psychotherapeutic alliance. Biofeed-
back’s mechanism of action may actually be altering
more basic endophenotypic substrates of impulsivity,
represented for instance by electrocortical measure-
ments such as the contingent negative variation.
The clinical usefulness of this narrowly deﬁned focus
gains support in the ﬁnding of lowered electroder-
mal responsiveness in borderline personality disor-
der and ASPD, a trait which has been postulated
to lead to risk-taking and impulsive behaviours
(Herpetz et al., 2001). Furthermore, for conﬁned
or incarcerated patients, biofeedback treatments
would be less dependent on the therapeutic milieu
than traditional psychotherapies.
The possibility that biofeedback could be
ameliorative for some of the most problematic
manifestations of severely personality disordered
patients is an exciting avenue for further explora-
tion. However, because of the naturalistic nature
of this study and the presence of several psychiat-
ric co-morbidities in MN, caution is advised in
extending the ﬁndings from this case study to
personality disorders in general. For example, the
presence of attentional defects in this forensic
patient complicates the understanding of the
mechanism of MN’s improvement with biofeed-
back. The evaluation of this patient might have
been strengthened by more deﬁnitive clinical
and neuropsychological evaluation for ADHD/
ADD, as it could be argued that his favourable
response to biofeedback represented a positive
response in ADHD symptoms. The evidence base
for efﬁcacy of biofeedback therapies for ADHD/
ADD is more robust than that for personality dis-
orders (Lubar, 1991; van Outsem, 2011). Rossiter
and La Vaque (1995) found signiﬁcant reductions
in behavioural and cognitive symptoms in a group
of patients with DSM-deﬁned ADHD treated with
20 sessions of biofeedback over a 4–7-week period.
Degree of improvement with biofeedback compared
favourably with that seen with the study subjects
treated only with psychostimulants. A comprehen-
sive review of neurofeedback therapies in ADHD
showed positive outcomes in approximately 80%
of patients (van Outsem, 2011). In his review of
biofeedback for forensic patients, van Outsam
places biofeedback’s evidence for treatment efﬁcacy
in ADHD in the highest group (category A), along
with pervasive developmental disorder/autism and
substance abuse disorders, whereas biofeedback for
personality disorders does not even warrant inclu-
sion in the lowest evidence group (category C).
And although van Outsam offers—as pointed out
by Howard et al. in the complex case report—that
biofeedback could conceivably play a role in
the treatment of personality disorders, he prefaces
this speculation with the observation that ‘. . .there
is insufﬁcient evidence that neurofeedback could
reduce aggressive or anti-social behaviour in
patients suffering from personality disorders.’(van
Outsem, 2011)
In summary, by using the case ofMN, the authors
have stimulated interest in utilizingbiofeedback for a
challenging group of patients who are often treated
unsuccessfully with medications and/or traditional
psychotherapies. The case of MN illustrates the
complexity of these patients with the frequent pres-
ence of multiple comorbities. The ﬁeld of forensic
psychiatry could beneﬁt greatly from further study
of the use of biofeedback as an addition to its thera-
peutic armamentarium. Further avenue for clinical
research in forensic patients might involve a focus
on whether the biobehavioral and neurophysiologic
changes translate into improvements in clinical out-
come (e.g. length of stay and recidivism).
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